Article Reflects on NICE’s Achievements, Economic Evaluation Methods
University of York's Mark Sculpher and Stephen Palmer in a recent article published in PharmacoEconomics discuss the National Institute for [...]
Wynne Health Group’s LaRosa Talks Drug Pricing Intiatives
Josh LaRosa, policy director at Wynne Health Group, in a new Relentless Health Value podcast highlights a number of drug [...]
Express Scripts Releases Annual Drug Trend Report
Express Scripts in its annual Drug Trend Report suggests drugs targeting inflammatory conditions were responsible for almost half of the [...]
COTA White Paper Spotlights Perspectives on RWE
A new white paper from COTA offers unique perspectives on real-world evidence (RWE), including input from Pfizer and Bristol-Myers Squibb [...]
Amyrt’s Myalept Tops Ranking of Pharmacy Drugs by Price
Amyrt Pharma's Myalept is the most expensive pharmacy drug at $71,306 per month, according to a GoodRx report which ranks [...]
ISPOR Launches International Search for New Editor-in-Chief of Value & Outcomes Spotlight Magazine
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is launching an international search for a new editor-in-chief for its [...]
Lown Institute’s Saini, Brownlee Talk Shkreli Awards
Lown Institute's Vikas Saini, president, and Shannon Brownlee, senior vice president, discuss the latest Shkreli Awards winners on the Relentless [...]
Randomization vs. Real-World Evidence
Nonrandomized observational studies have been touted by some as being a viable alternative to randomized clinical trials, but are they [...]
Report Outlines How States Can Act on Drug Spending
A recent report by the Center for American Progress outlines how states can take action to reduce prescription drug spending. [...]
Massachusetts to Pay for Zolgensma on One Condition: It Must Work
Massachusetts' Medicaid program, MassHealth, has inked a conditional deal for Novartis' $2 million one-time spinal muscular atrophy (SMA) gene therapy, [...]
PRMA’s White Outlines Expanded U.S. Presence
PRMA Consulting's Nathan White, senior principal and U.S. practice lead, in a recent interview outlines the agency's latest expansion in [...]
ICER’s Whitrap: Not All Investors See Only Dollar Signs
David Whitrap, Institute for Clinical and Economic Review vice president of communications and outreach, in a recent post says some [...]
Study: Reference Pricing Leads to Lower Drug Spending for Employers
A recent study published in JAMA suggests reference pricing used in employer-sponsored health plans could help employers reduce their drug [...]
Rosenthal Blasts Health System, Policymakers on Surprise Bills
Journalist and physician Elisabeth Rosenthal in a recent opinion piece published on the New York Times criticizes the health care [...]
Price of Decades-Old Drug Skyrockets, Georgia City Sues
The price of Belcher Pharmaceuticals' Acthar gel skyrocketed after having been granted orphan status by the Food and Drug Administration, [...]
Study: Drug Price Hikes Were Main Driver of Increased Health Spending by Employer-Sponsored Plans
A new released Thursday by the Health Care Cost Institute (HCCI) found that prescription drug price hikes were the main [...]
2020 CADTH Symposium Issues Call for Late-Breaking Abstracts
CADTH announced this week that it is accepting late-breaking abstracts for its upcoming 2020 CADTH Symposium set to begin April [...]
MAPS Appoints Dwyer as First Chair of New Committee
The Medical Affairs Professional Society (MAPS) appointed medical affairs consultant Mary Dwyer as the first chair of its Executive Program [...]
ISMPP Announces Keynote Speakers for Upcoming Meeting
The International Society for Medical Publication Professionals (ISMPP) announced its lineup of keynote speakers for its annual meeting set to [...]
Avalere Plans Webinar on Medicaid Drug Pricing
An upcoming webinar hosted by Avalere Health is set to discuss how states and the federal government are working to [...]
Study: 1 in 5 Encounter Surprise Bills for Surgery
A recent study published in JAMA suggests that 1 in 5 insured patients received a surprise bill following surgery. Researchers [...]
CTI Announces New Promotions
CTI Clinical and Consulting Services (CTI) this week announced promotions for two of its staff members, Ana Patacão and Brian [...]
ISPOR-FDA Summit 2020 Nears
A joint summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Food and Drug Administration (FDA) [...]
ISPOR to Host Webinar on Patient-Preference Information
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar March 4 on patient-preference methods [...]
More on Report from Pioneer Institute on QALY
Pharmaphorum in a recent report highlights a new analysis by the Pioneer Institute that suggests the Institute for Clinical and [...]